AbbVie Long Term Debt 2012-2026 | ABBV

AbbVie long term debt for the quarter ending March 31, 2026 was $62.971B, a 7.63% increase year-over-year.

  • AbbVie long term debt for 2024 was $60.34B, a 15.61% increase from 2023.
  • AbbVie long term debt for 2023 was $52.194B, a 11.74% decline from 2022.
  • AbbVie long term debt for 2022 was $59.135B, a 7.87% decline from 2021.

AbbVie Long Term Debt 2012-2026 | ABBV

  • AbbVie long term debt for 2024 was $60.34B, a 15.61% increase from 2023.
  • AbbVie long term debt for 2023 was $52.194B, a 11.74% decline from 2022.
  • AbbVie long term debt for 2022 was $59.135B, a 7.87% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B